Multiple reports claim a largely symptom-less condition identified through blood tests causes about 45,000 deaths each year in the UK. The articles say the figure exceeds deaths attributed to breast and prostate cancer combined and note that many people have not heard of the condition.
The sources do not provide consistent public details about the specific diagnosis, how it is defined clinically, or what blood-test markers are used in the reporting provided. They also do not describe how the figure compares to official cancer mortality statistics or specify whether the 45,000 estimate comes from recent epidemiological data. The framing emphasizes limited public awareness and the role of blood testing, but without additional corroborating context in the material shared.
Overall, the coverage centers on raising awareness rather than reporting new clinical findings, while leaving key factual specifics—such as the exact condition name, diagnostic criteria, and sourcing of mortality estimates—unclear from the excerpts.
